FERRING Pharmaceuticals
ulcerative colitis therapy Cortiment
(budesonide) has received an
Australian Public Assessment
Report from the Therapeutic Goods
Administration.
The orally administered product
is given for induction of remission
at the rate of one 9mg tablet in the
morning for up to 8 weeks.The above article was sent to subscribers in Pharmacy Daily's issue from 18 Feb 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Feb 16
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.